Barry O'Leary, CEO of IDA Ireland, presented on the current impact of foreign direct investment in Ireland. IDA portfolio companies currently employ over 250,000 people and contribute €115 billion to the Irish economy. Recent investments include expansions and new facilities by pharmaceutical and biopharmaceutical companies in Cork, Dublin, Sligo, and Galway, creating over 1,500 new jobs. Initiatives to support Ireland's pharmaceutical cluster include the Solid State Pharma Cluster and the National Institute for Bioprocessing Research and Training. World competitiveness rankings show Ireland is highly ranked for factors that attract foreign investment such as skilled labor, investment incentives, tax rates, and adaptability. The FDI outlook remains positive with a strong pipeline

1. Barry O’Leary
CEO IDA Ireland
October 31 2012

2. Current Impact of FDI
IDA Portfolio Companies
250,000
€115 billion

3. Current Impact of FDI
Two thirds
Business Expenditure on R&D

4. IDA Business Focus

5. IDA focus across industry segments
Leading MNCs
2nd Tier
Emerging Companies

6. Some wins to-date: January – October 2012

7. Ireland – Pharma / BioPharma Cluster

8. Lifescience Shared Services

9. Key Recent Pharma/Biopharma Investments
New Expansion of Galway & Dublin;
biopharmaceutical development and Expansion of Sligo Development,
Dun Laoghaire
facility in Cork manufacturing Pharmaceutical Manufacturing and
Facility in Dublin
operations Plant Supply Chain
$200m / 100 Jobs Management
$420m / 200 Jobs $350m / 200 Jobs $110m / 175 Jobs
$ 500m / 500 Jobs
Bioassay Centre of
Expansion of European HQ Sales
Cork Manufacturing Expertise
biotech campus in and Manufacturing
Plant /Pneumococcal
Grange Castle, Base
Vaccine Conjugation
Dublin
$50m / 100 jobs Facility
120 jobs
€29m
$200m

10. Initiatives to support Pharma / Biopharma Cluster
 Solid State Pharma Cluster
ACADEMIA INDUSTRY
 Pharmaceutical Manufacturing Technology Centre
 National Institute for Bioprocessing Research and Training (NIBRT)

11. What attracts FDI to Ireland?
• Talent, Technology, Track Record (operational excellence), Tax,
• Ease of doing Business , EU Access, English speaking are building blocks…
• Sector / Activity / Country Specific
• Ireland’s Value Proposition - Needs Constant Enhancement
Example – Biopharmaceuticals;
- FDA Track Record TEAM IRELAND
- National Institute for Bioprocessing and Research Training (NIBRT)
- Science Foundation Ireland Initiatives
- Strategic Sites
- Cluster Impact
- Financial Incentives
- Regulatory Environment

12. World Competitiveness Rankings
IBM PLI Global Location Trends Report 2011;
 2nd ranked destination by jobs per 100,000 inhabitants
 1st ranked destination by value* of Investment projects
* a combination of Productivity, value-added, knowledge
intensity and occupational profile composition
Up 4 Places to Number
20
IMD World Competiveness Yearbook 2012
 1st in the world for ready availability of skilled labour
 1st for flexibility and adaptability of people to challenges
 1st for investment incentives to attract foreign investors
 2nd for positive attitudes towards globalization
 2nd for adaptability of companies to market changes
 3rd for unit labour costs in the manufacturing sector
 3rd in the world for labour productivity
 4th for corporate tax rate on profit

13. FDI Outlook
• Good immediate pipeline in Technology (ICT) Sector, Lifesciences, Financial Services,
Digital media / Content, Professional / International Services
• Flat European Market
– Importance for FDI
– Global Outlook
• IDA needs to have more than 100+ investments
in play at any one time
• Pipeline generation and conversion is a key focus

14. Thank You